Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2009 1
2010 1
2011 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug.
Caselli G, Bonazzi A, Lanza M, Ferrari F, Maggioni D, Ferioli C, Giambelli R, Comi E, Zerbi S, Perrella M, Letari O, Di Luccio E, Colovic M, Persiani S, Zanelli T, Mennuni L, Piepoli T, Rovati LC. Caselli G, et al. Among authors: ferioli c. Arthritis Res Ther. 2018 Mar 1;20(1):39. doi: 10.1186/s13075-018-1537-8. Arthritis Res Ther. 2018. PMID: 29490676 Free PMC article.
Guidelines for the use of RFID technology in transfusion medicine.
Knels R, Ashford P, Bidet F, Böcker W, Briggs L, Bruce P, Csöre M, Distler P, Gutierrez A, Henderson I, Hohberger C, Holcombe J, Holmberg J, Hulleman R, Marcel B, Messenger P, Mun I, Roberts S, Sandler G, Veeramani R, Wray B; Task Force on RFID of the Working Party on Information Technology; International Society of Blood Transfusion. Knels R, et al. Vox Sang. 2010 Apr;98 Suppl 2:1-24. doi: 10.1111/j.1423-0410.2010.01324.x. Vox Sang. 2010. PMID: 20579330 No abstract available.
Synthesis, pharmacophore modeling and in vitro activity of 10,11-dihydrodibenzo[b,f]oxepine-4-carboxamide derivatives as novel and potent antagonists of the prostaglandin EP4 receptor.
Stasi LP, Bhimani K, Borriello M, Canciani L, Caselli G, Colace F, Ferioli C, Kaswala M, Mennuni L, Piepoli T, Pucci S, Salvi M, Shirsath V, Zanelli T, Zerbi S. Stasi LP, et al. Among authors: ferioli c. Bioorg Med Chem Lett. 2011 Nov 1;21(21):6336-40. doi: 10.1016/j.bmcl.2011.08.102. Epub 2011 Sep 1. Bioorg Med Chem Lett. 2011. PMID: 21930381